AIS	Adenocarcinoma in situ
ASC-H	Atypical squamous cells—cannot exclude HSIL
ASC-H+	Atypical squamous cells—cannot exclude HSIL or worse
ASC-US	Atypical squamous cells of undetermined significance
ASC-US+	Atypical squamous cells of undetermined significance or worse
CI	Confidence interval
CIN2	Cervical intraepithelial neoplasia grade 2
CIN2+	Cervical intraepithelial neoplasia grade 2 or worse
CIN3	Cervical intraepithelial neoplasia grade 3
CIN3+	Cervical intraepithelial neoplasia grade 3 or worse
DNA	Deoxyribonucleic acid
E6/E7	Early genes E6 and E7
HPV	Human papillomavirus
HSIL	High-grade squamous intraepithelial lesion
ISC	Intrinsic sample control
LBC	Liquid-based cytology
LIS	Laboratory information system
LSIL	Low-grade squamous intraepithelial lesion
mRNA	Messenger RNA
NASBA	Nucleic acid sequence-based amplification
NILM	Negative for intraepithelial lesion or malignancy
NPV	Negative predictive value
PPV	Positive predictive value
PreTect SEE	Genotype-specific HPV E6/E7 mRNA test (HPV16/18/45)
REC	Regional Committee for Medical and Health Research Ethics (REC Nord)
RR	Risk ratio
SCC	Squamous cell carcinoma
ThinPrep	ThinPrep liquid-based cytology system
UNN	University Hospital of North Norway